Literature DB >> 22477503

New fibrillin gene mutation - possible cause of ascending aortic dilation in patients with aortic valve disease: Preliminary results.

Ján Dudra1, Jaroslav Lindner, Ivan Vaněk, Jana Simova, Ivan Mazura, Ivo Miler, Jana Ciháková, Pavel Capek, Josef Belák.   

Abstract

BACKGROUND: Approximately 10% of patients who undergo surgery for aortic valve disease (stenosis or regurgitation) suffer from ascending aortic dilation (AAD). A possible genetic etiology of AAD associated with aortic valve disease has been repeatedly mentioned in the literature, but a specific responsible gene mutation has not been described.
METHODS: In the present study, two groups of patients were compared, all of whom underwent surgery for aortic valve disease. Group A was a cohort of 27 patients who suffered from aortic valve disease associated with AAD. Group B was a cohort of 29 patients with structural aortic valve disease, but without concomitant AAD (control group). Genomic DNA was extracted from the white blood cells of peripheral blood samples and was amplified using primers specific for chosen exons of the fibrillin-1 gene, including their intron/exon boundaries. Exons 26 and 27 were selected for analysis.
RESULTS: Analysis of the intronic part situated close to exon 27 showed insertion of cytosine between nucleotide 37 682 and 37 683 of query sequence. This insertions was classified as IVS 37 682 and 37 683insC. This mutation was found in all 27 patients from group A (patients with structural aortic valve disease accompanied by significant AAD). The abovementioned mutation was not found in any of the 29 patients from group B.
CONCLUSIONS: This finding has potential implications for risk stratification and therapeutic targeting not only for patients with existing disease, but also for the general population. Future studies are needed to determine the clinical utility of the finding; however, the present hypothesis needs to be verified by further molecular studies.

Entities:  

Year:  2009        PMID: 22477503      PMCID: PMC2780856          DOI: 10.1055/s-0031-1278335

Source DB:  PubMed          Journal:  Int J Angiol        ISSN: 1061-1711


  10 in total

1.  Dilation of the ascending aorta due to medial degeneration.

Authors:  Tirone E David
Journal:  J Heart Valve Dis       Date:  2003-03

2.  Bicuspid versus tricuspid aortic valves.

Authors:  Francis Robicsek
Journal:  J Heart Valve Dis       Date:  2003-01

3.  Dealing with dilated ascending aorta during aortic valve replacement: advantages of conservative surgical approach.

Authors:  T Carrel; L von Segesser; R Jenni; A Gallino; L Egloff; E Bauer; A Laske; M Turina
Journal:  Eur J Cardiothorac Surg       Date:  1991       Impact factor: 4.191

4.  Targetting of the gene encoding fibrillin-1 recapitulates the vascular aspect of Marfan syndrome.

Authors:  L Pereira; K Andrikopoulos; J Tian; S Y Lee; D R Keene; R Ono; D P Reinhardt; L Y Sakai; N J Biery; T Bunton; H C Dietz; F Ramirez
Journal:  Nat Genet       Date:  1997-10       Impact factor: 38.330

Review 5.  The molecular genetics of Marfan syndrome and related microfibrillopathies.

Authors:  P N Robinson; M Godfrey
Journal:  J Med Genet       Date:  2000-01       Impact factor: 6.318

6.  Purification and partial characterization of fibrillin, a cysteine-rich structural component of connective tissue microfibrils.

Authors:  L Y Sakai; D R Keene; R W Glanville; H P Bächinger
Journal:  J Biol Chem       Date:  1991-08-05       Impact factor: 5.157

7.  Mutations of extracellular matrix components in vascular disease.

Authors:  F Ramirez; L Pereira
Journal:  Ann Thorac Surg       Date:  1999-06       Impact factor: 4.330

8.  Delineation of the Marfan phenotype associated with mutations in exons 23-32 of the FBN1 gene.

Authors:  E A Putnam; M Cho; A B Zinn; J A Towbin; P H Byers; D M Milewicz
Journal:  Am J Med Genet       Date:  1996-03-29

9.  TGGE screening of the entire FBN1 coding sequence in 126 individuals with marfan syndrome and related fibrillinopathies.

Authors:  Stefanie Katzke; Patrick Booms; Frank Tiecke; Monika Palz; Angelika Pletschacher; Seval Türkmen; Luitgard M Neumann; Reinhard Pregla; Christa Leitner; Cornelia Schramm; Peter Lorenz; Christian Hagemeier; Josefine Fuchs; Flemming Skovby; Thomas Rosenberg; Peter N Robinson
Journal:  Hum Mutat       Date:  2002-09       Impact factor: 4.878

10.  Four novel FBN1 mutations: significance for mutant transcript level and EGF-like domain calcium binding in the pathogenesis of Marfan syndrome.

Authors:  H C Dietz; I McIntosh; L Y Sakai; G M Corson; S C Chalberg; R E Pyeritz; C A Francomano
Journal:  Genomics       Date:  1993-08       Impact factor: 5.736

  10 in total
  1 in total

1.  Letter to the editor.

Authors:  Gavin Arno; Paolo Comeglio; Anne H Child
Journal:  Int J Angiol       Date:  2010
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.